Anika Therapeutics Inc

General

Total Cases5
Active Cases--
Patents16
TypeOperating Company
Elite Ratings
--

Ratings

Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
04/29/24
Patent Report electronically sent to the U.S. Patent and Trademark Office. (KME) (Entered: 04/29/2024)
04/29/24
NOTICE of Local Rule 1.11(e), which provides that, unless an order states another time, a seal under Rule 1.11 expires ninety days after a case is closed and all appeals are exhausted. To prevent the content of a sealed item from appearing on the docket after the seal expires, a party or interested non-party must move for relief before the seal expires. (Signed by Deputy Clerk). (KME) (Entered: 04/29/2024)
04/26/24
TEXT ORDER. The parties have filed a Stipulation of Dismissal with Prejudice (Doc. 103). The Stipulation is self-executing. See Fed. R. Civ. P. 41(a)(1)(A)(ii); Anago Franchising, Inc. v. Shaz, LLC, 677 F.3d 1272, 1278 (11th Cir. 2012). Accordingly, the Clerk of Court is DIRECTED to terminate any pending deadlines and motions and close the file. Signed by Judge John L. Badalamenti on 4/26/2024. (AMB) (Entered: 04/26/2024)
04/25/24
STIPULATION of Dismissal with Prejudice by Arthrex, Inc.. (Tobin, Brian) (Entered: 04/25/2024)
04/01/24
ENDORSED ORDER granting 100 the parties' joint motion to amend the scheduling order as the court finds good cause to amend under Rule 16(b). By May 3, 2024, the opposing party's expert disclosures must be completed. The other provisions of the fifth amended scheduling order (Doc. 96) remain in effect. Signed by Magistrate Judge Nicholas P. Mizell on 4/1/2024. (TLP) (Entered: 04/01/2024)
03/29/24
MEDIATION report Hearing held on March 26, 2024. Hearing outcome: The parties have reached a resolution in principle but have filed a motion [D.E. 100] in which they request that the deadline for serving rebuttal expert reports (only) be stayed for 14 days in light of the need for more time to finalize the terms in a written and signed agreement. The parties also request that this Honorable Court keep this case active and not administratively close this case at this time.. (Matulis, James) (Entered: 03/29/2024)
03/28/24
Joint MOTION to Modify 96 Case Management Scheduling Order by Arthrex, Inc. (Tobin, Brian) Motions referred to Magistrate Judge Nicholas P. Mizell. Modified text on 3/29/2024 (BD). (Entered: 03/28/2024)
02/13/24
NOTICE of Appearance by Jodi-Ann Tillman on behalf of Anika Therapeutics, Inc., Parcus Medical, LLC (Tillman, Jodi-Ann) (Entered: 02/13/2024)
02/13/24
NOTICE of Appearance by Jodi-Ann Tillman on behalf of Anika Therapeutics, Inc., Parcus Medical, LLC (Tillman, Jodi-Ann) (Entered: 02/13/2024)
01/12/24
ENDORSED ORDER granting 97 defendants' construed unopposed motion to amend the scheduling order. While Rule 16 governs the motion and plaintiff fails to cite or apply the correct rule, the court nevertheless finds good cause to amend the schedule. By January 16, 2024, defendants must submit their amendment of non-infringement and invalidity contentions and disclosure of intent to rely on advice of counsel as defense. All other deadlines and provisions of the fifth amended scheduling order (Doc. 96) remain in effect. Signed by Magistrate Judge Nicholas P. Mizell on 1/12/2024. (TLP) (Entered: 01/12/2024)